This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
LEF1 antibody
catalog :
VMA00706KT
quantity :
2 Westerns
price :
108 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1866CT359.68.92.75
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb™ Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00706KT
Description :
LEF1 ANTIBODY WITH CONTROL LYSATE
Specificity :
LEF1
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Clone :
1866CT359.68.92.75
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0001649, GO:0001837, GO:0042393, GO:0005737, GO:0005667, GO:0008013, GO:0008284, GO:0008301, GO:0010552, GO:0010718, GO:0010843, GO:0016563, GO:0016564, GO:0021987, GO:0022408, GO:0022409, GO:0030223, GO:0030284, GO:0030307, GO:0030331, GO:0030335, GO:0030854, GO:0032582, GO:0032696, GO:0032713, GO:0032714, GO:0032993, GO:0035326, GO:0043027, GO:0043154, GO:0043392, GO:0043923, GO:0043966, GO:0043967, GO:0045063, GO:0045295, GO:0045892, GO:0045893, GO:0060021, GO:0060070, GO:0060326, GO:0070016, GO:0070742, GO:0071353, GO:0071864, GO:0071866, GO:0071899, GO:0090068, GO:0090090
GOTerms :
activation of cell growth, activation of cell migration, activation of cell proliferation, activation of cell proliferation in bone marrow, activation of cell-cell adhesion, activation of granulocyte differentiation, activation of transcription, DNA-dependent, Arm repeat domain binding, armadillo domain binding, armadillo repeat binding, canonical Wnt signaling pathway, cellular response to IL-4, DNA binding, transcription promoter, DNA-protein complex, down regulation of apoptosis in bone marrow, down regulation of caspase activity, down regulation of cell-cell adhesion, down regulation of DNA binding, down regulation of gene-specific transcription, down regulation of interleukin-13 production, down regulation of interleukin-4 production, down regulation of interleukin-5 production, down regulation of transcription, DNA-dependent, downregulation of apoptosis in bone marrow, down-regulation of apoptosis in bone marrow, downregulation of caspase activity, down-regulation of caspase activity, down-regulation of cell-cell adhesion, downregulation of cell-cell adhesion, downregulation of DNA binding, down-regulation of DNA binding, down-regulation of gene-specific transcription, downregulation of gene-specific transcription, down-regulation of interleukin-13 production, downregulation of interleukin-13 production, down-regulation of interleukin-4 production, downregulation of interleukin-4 production, down-regulation of interleukin-5 production, downregulation of interleukin-5 production, down-regulation of transcription, DNA-dependent, downregulation of transcription, DNA-dependent, EMT, epithelial-mesenchymal transition, frizzled-1 receptor signaling pathway, GO:0001719, GO:0003710, histone-specific chaperone activity, inhibition of apoptosis in bone marrow, inhibition of caspase activation, inhibition of caspase activity, inhibition of cell-cell adhesion, inhibition of DNA binding, inhibition of gene-specific transcription, inhibition of interleukin-13 production, inhibition of interleukin-4 production, inhibition of interleukin-5 production, inhibition of transcription, DNA-dependent, negative regulation of bone marrow cell apoptosis, negative regulation of bone marrow cell programmed cell death by apoptosis, negative regulation of canonical Wnt receptor signalling pathway, negative regulation of caspase activation, negative regulation of cellular transcription, DNA-dependent, negative regulation of IL-13 production, negative regulation of IL-4 production, negative regulation of IL-5 production, negative regulation of killing of bone marrow cells, negative regulation of programmed cell death of bone marrow cells by apoptosis, negative regulation of programmed cell death, bone marrow cells, negative regulation of Wnt receptor signaling pathway through beta-catenin, negative transcriptional regulator activity, neocortex development, neutrophil cell differentiation, neutrophil granulocyte differentiation, neutrophil granulocytopoiesis, osteoblast cell differentiation, palatum development, plakoglobin binding, positive regulation of bone marrow cell proliferation, positive regulation of cellular transcription, DNA-dependent, positive regulation of viral transcription by host, stimulation of cell growth, stimulation of cell migration, stimulation of cell proliferation, stimulation of cell proliferation in bone marrow, stimulation of cell-cell adhesion, stimulation of granulocyte differentiation, stimulation of transcription, DNA-dependent, T-helper 1 cell development, transcription activating factor, transcriptional activator activity, transcriptional repressor activity, up regulation of cell growth, up regulation of cell migration, up regulation of cell proliferation, up regulation of cell proliferation in bone marrow, up regulation of cell-cell adhesion, up regulation of granulocyte differentiation, up regulation of transcription, DNA-dependent, upregulation of cell growth, up-regulation of cell growth, upregulation of cell migration, up-regulation of cell migration, upregulation of cell proliferation, up-regulation of cell proliferation, upregulation of cell proliferation in bone marrow, up-regulation of cell proliferation in bone marrow, up-regulation of cell-cell adhesion, upregulation of cell-cell adhesion, upregulation of granulocyte differentiation, up-regulation of granulocyte differentiation, up-regulation of transcription, DNA-dependent, upregulation of transcription, DNA-dependent, Wnt receptor signaling pathway through beta-catenin, Wnt receptor signaling pathway via beta-catenin, Wnt receptor signalling pathway through beta-catenin
UniprotAccessions :
Q9UJU2
Gene :
LEF1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51176
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - Liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments